Fan Yu
- SEC CIK
- 0001668029
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed Sep 17, 2021. Long positions only.
- Positions
- 5
- No 13F data for Q4 2020
- Portfolio value
- $38.3M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AVIRAtea Pharmaceuticals, Inc. | COM | 300,000 | $18.5M | 48.4% | – | – | History |
| LUNGPulmonx Corp | COM | 303,030 | $13.9M | 36.2% | – | – | History |
| ABGIABG Acquisition Corp. I | CL A SHS | 501,300 | $4.96M | 12.9% | – | – | History |
| SYRESpyre Therapeutics, Inc. | COM | 112,044 | $887.0K | 2.3% | – | – | History |
| Diffusion Pharmaceuticals IN253748305 | COM PAR | 89,848 | $82.0K | 0.2% | – | – | – |